65,437 trials
Open Angle Glaucoma · Ocular Hypertension
Primary: Change From Baseline in the Mean Diurnal IOP Within Each Treatment Arm — -2.4; -3.2; -3.1; -3.1 mmHg — p=0.93
Spinal Cord Injuries · Spinal Cord Diseases
Primary: HIIT Times — 10 Intervals
Chronic Low Back Pain
Primary: LS Mean Reduction in Oswestry Disability Index (ODI) From Baseline — 25.95 units on a scale of 0 to 100 points — p=0.001
Diabetes
Primary: Number of Day Until 50% Healing of Leg Ulcer — 55; 30 Days
Spinal Cord Injury
Primary: Physiology Measurements Before and After rTMS/Sham rTMS Protocol- Changes in Amplitude of Motor Evoked Potential (MEP) From TMS — 0.31; 0.43; 0.45; 0.65 millivolts (mV)
Onychomycosis
Primary: The Proportion of Subjects in the Intent-to-treat Population With Complete Cure, Defined as Clinical AND Mycological Cure, at Week 48 — 17; 19; 22; 18 Participants
Hearing Loss
Primary: Percentage of Words Correct on AzBio Sentences in Noise S0N90 — 72.1 percentage of words correct
Chronic Spontaneous Urticaria
Primary: Change From Baseline of the Itch Severity Score (ISS7) Score After 12 Weeks of Treatment — -10.11; -9.66; -5.87 Score on a scale — p=<0.001
COVID 19
Primary: Number of Cured Patients — 16 Participants
Obesity · Diabetes · Cardiovascular Disease
Primary: Total Energy Expenditure, Assessed by Indirect Calorimetry Using Stable Isotopes — 2713; 2504; 2640; 190 kcal/d
Malignant Tumors
Primary: EORTC-QLQ-C30 Score — 51.2; 46.6 score on a scale — p=0.397
Stress Disorders, Post-Traumatic
Primary: Change in PTSD Severity as Measured by the PTSD Checklist (PCL-5) — 59.82; 60.45; 33.29; 39.14 score on a scale
Breast Cancer
Primary: Number of Participants With Detected Lymph Nodes — 145 Participants
Obesity
Primary: Attendance — 11; 8; 2; 12 Participants
Homozygous Familial Hypercholesterolemia HoFH
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 10 Participants